Transcutaneous Spinal Cord Stimulation for Upper Extremity Function

Inclusion Criteria

• •SCI cohort:
• •individuals aged 18 to 75 years of age who have suffered a spinal cord injury
• •cervical level injury (C3 to C8)
• •at least 1-year post-injury
• •for individuals taking medications for spasmolysis or muscle relaxation (e.g. oral baclofen, tizanidine, dantrolene, vigabatrin, gabapentin, or benzodiazepine), dose and regimen must be stable for at least 4 weeks prior to screening
• •Stroke cohort:
• •individuals aged 18-75 years of age who have suffered any type of stroke resulting in upper extremity motor dysfunction with partially preserved motor function
• •≥ 6 months post-stroke
• •At least 4 months since last BoNT injection for treatment of spasticity or any other condition or ≤ 2 months after study completion
• •for individuals taking medications for spasmolysis or muscle relaxation (e.g. oral baclofen, tizanidine, dantrolene, vigabatrin, gabapentin, or benzodiazepine), dose and regimen must be stable for at least 4 weeks prior to screening